A) Prognostic values of various parameters on overall survival | ||||
---|---|---|---|---|
N = 197 (93 events) | Univariate | Multivariable | ||
 | HR (CI95%) | p | HR (CI95%) | p |
Age (continuous, per decade) | 1.35 (1.14-1.60) | <0.001 | 1.26 (1.07-1.48) | 0.006 |
FIGO (ordinal, per stage) | 2.22 (1.44-3.42) | <0.001 | 2.18 (1.38-3.45) | <0.001 |
Residual tumor (yes vs. no) | 2.01 (1.32-3.06) | 0.001 | 1.87 (1.21-2.88) | 0.005 |
CD8+ cell infiltration (continuous, per doubling) | 0.86 (0.77-0.96) | 0.006 | 0.82 (0.73-0.92) | <0.001 |
Ki67+ tumor cells (<5% vs. ≥5%) | 3.27 (1.57-6.83) | 0.002 | 3.34 (1.59-7.04) | 0.001 |
B) Prognostic values of various parameters on progression-free survival | ||||
N = 180 (139 events) | Univariate | Multivariable | ||
 | HR (CI95%) | p | HR (CI95%) | p |
Age (continuous, per decade) | 1.18 (1.03-1.34) | 0.016 | 1.08 (0.94-1.23) | 0.268 |
FIGO (ordinal, per stage) | 2.51 (1.72-3.67) | <0.001 | 2.19 (1.43-3.35) | <0.001 |
Residual tumor (yes vs. no) | 2.07 (1.44-2.98) | <0.001 | 1.64 (1.11-2.43) | 0.013 |
CD8 cell infiltration (continuous, per doubling) | 0.97 (0.89-1.05) | 0.447 | 0.92 (0.84-1.01) | 0.074 |
Ki67 (<5% vs. ≥5%) | 1.63 (0.76-3.49) | 0.209 | 1.51 (0.69-3.28) | 0.299 |